论文信息 - The safety and immunogenicity of a human immunodeficiency virus type 1 (HIV-1) recombinant gp160 candidate vaccine in humans. NIAID AIDS Vaccine Clinical Trials Network. - 字舞流文

The safety and immunogenicity of a human immunodeficiency virus type 1 (HIV-1) recombinant gp160 candidate vaccine in humans. NIAID AIDS Vaccine Clinical Trials Network.

C. Tacket | R. Belshe | B. Graham | M. Clements | R. Atmar | G. Gorse | R. Dolin | K. Midthun | S. Greenberg | B. W. Horgan